Professor Andy Davies

Professor Andy Davies

BSc (Hons) BM (Hons) PhD FRCP

Professor of Haematological Oncology

Connect with Andy

Email: A.Davies@soton.ac.uk

Tel: +44 23 8120 6186

ORCID

Research

Research groups

Member of:

Research projects

Active projects

Experimental Cancer Medicines Centre (ECMC) 2022 QQR

Researchers:

Professor Andy Davies

Sponsor: Cancer Research UK

CRUK Clinical Academic Training Programme 2024

Researchers:

Professor Andy Davies

Professor Ellen Copson

Experimental Cancer Medicines Centre (ECMC) 2022 QQR

Researchers:

Professor Andy Davies

Cost-effective multi-cancer early detection by measuring patient plasma amino acid cross sections with the Enlighten test

Researchers:

Professor Andy Davies

Professor Simon Crabb ,

Mr Sam Wilding ,

Professor Gareth Griffiths ,

Professor Joanne Lord

Optimizing MATrix as remission induction treatment for newly diagnosed primary CNS Lymphoma – a randomized phase III trial (OPTIMATE trial)

Researchers:

Professor Gareth Griffiths

Professor Andy Davies

Sponsor: Cancer Research UK

miONCO-Dx : A novel multi cancer early diagnostic test

Researchers:

Professor Paul Skipp

Professor David Scott ,

Professor Andy Davies ,

Mr Sam Wilding

(MAIN STUDY) SAFE-D: Surveillance of pAncreatic pathology aFtEr Diabetes diagnosis

Researchers:

Professor Gareth Griffiths

Doctor Victoria Goss ,

Professor Andy Davies ,

Doctor Mark Lown

Completed projects

Treating Multiple Myeloma and Diffuse Large B Cell Lymphoma by Targeting the NF-κB Pathway with the First-in-Class GADD45β/MKK7 Inhibitor, DTP3

Researchers:

Professor Andy Davies

Professor Peter Johnson

Sponsor: Medical Research Council

TAP Centre within TAP Network

Researchers:

Professor Andy Davies

Sponsor: Cure Leukaemia

An open, prospective Phase III clinical study to compare polatuzumab vedotin plus rituximab, ifosfamide, carboplatin and etoposide (PolaRICE) with rituximab, ifosfamide, carboplatin and etoposide (RICE)

Researchers:

Professor Andy Davies

Professor Gareth Griffiths

Researchers:

Professor Andy Davies

Molecular Profiling for Lymphoma Study

Researchers:

Professor Peter Johnson

Professor Andy Davies ,

Professor Gareth Griffiths

Sponsor: Blood Cancer UK

Johnson - LLR - 15002 - Precision medicine for aggressive lymphoma

Researchers:

Professor Peter Johnson

Professor Andy Davies ,

Professor Gareth Griffiths

Sponsor: Blood Cancer UK

Understanding and improving the mechanism of action of anti-GD2 monoclonal antibody therapy in neuroblastoma

Researchers:

Professor Juliet Gray

Professor Tony Williams ,

Professor Andy Davies

Sponsor: Childrens Cancer and Leukaemia Group

An Open Label Single Arm Phase II Study of Atezolizumab in patients with non-TCC of the bladder and urothelial tract

Researchers:

Professor Simon Crabb

Professor Andy Davies

Sponsor: Cancer Research UK

(PILOT) SAFE-D: Screening of pAncreatic pathology aFtEr Diabetes diagnosis

Researchers:

Professor Gareth Griffiths

Professor Andy Davies ,

Doctor Mark Lown